316 related articles for article (PubMed ID: 9043502)
1. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event.
Lu QL; Laniado M; Abel PD; Stamp GW; Lalani EN
Mol Pathol; 1997 Feb; 50(1):28-33. PubMed ID: 9208811
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
[TBL] [Abstract][Full Text] [Related]
5. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.
Bilim VN; Tomita Y; Kawasaki T; Takeda M; Takahashi K
Cancer Lett; 1998 Jun; 128(1):87-92. PubMed ID: 9652797
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer.
El-Sheikh SS; Madaan S; Alhasso A; Abel P; Stamp G; Lalani EN
BJU Int; 2001 Dec; 88(9):921-7. PubMed ID: 11851614
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
9. p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions.
Kamel D; Soini Y; Nuorva K; Khalifa A; Mangoud A; Vähäkangas K; Pääkkö P
Virchows Arch; 1994; 424(4):349-55. PubMed ID: 7911381
[TBL] [Abstract][Full Text] [Related]
10. P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.
Santos J; Fernandes E; Ferreira JA; Lima L; Tavares A; Peixoto A; Parreira B; Correia da Costa JM; Brindley PJ; Lopes C; Santos LL
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3329. PubMed ID: 25502795
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.
Helal Tel A; Fadel MT; El-Sayed NK
Pathol Oncol Res; 2006; 12(3):173-8. PubMed ID: 16998598
[TBL] [Abstract][Full Text] [Related]
14. p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder.
Asci R; Yildiz L; Sarikaya S; Buyukalpelli R; Yilmaz AF; Kandemir B
Urol Int; 2001; 67(1):34-40. PubMed ID: 11464113
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder.
Atuğ F; Türkeri L; Ozyürek M; Akdaş A
Int Urol Nephrol; 1998; 30(4):455-61. PubMed ID: 9821049
[TBL] [Abstract][Full Text] [Related]
16. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).
Badr KM; Nolen JD; Derose PB; Cohen C
Hum Pathol; 2004 Feb; 35(2):184-9. PubMed ID: 14991535
[TBL] [Abstract][Full Text] [Related]
17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
18. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
19. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.
Tungekar MF; Linehan J
J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815
[TBL] [Abstract][Full Text] [Related]
20. The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium.
Lin Z; Kim H; Park H; Kim Y; Cheon J; Kim I
Urol Res; 2003 Aug; 31(4):272-5. PubMed ID: 12879322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
